2269:HKG
WuXi Biologics (Cayman) Inc
48,20 HKD
arrow_downward
-0,90%(-0,44) 1D
16 paź, 16:08:14 GMT+8 · HKD
search
Wszystkie symbole
| Symbol | Cena | Zmiana | Zmiana % |
|---|
insights_autoGeneruję najważniejsze statystyki dotyczące: 2269…
Otwórz
49,98 HKD
Maks.
50,85 HKD
Min.
45,82 HKD
Kapitalizacja
198,43 mld
Śr. wol.
30,42 mln
Wolumen
55,18 mln
Wskaźnik C/Z
34,48
Najwyższa z 52 tyg.
58,00 HKD
Minimum z 52 tyg.
28,48 HKD
Zysk na akcję
1,40 HKD
Akcje w obiegu
1,23 mld
Liczba pracowników
15 tys.
Otwórz
49,98 HKD
Maks.
50,85 HKD
Min.
45,82 HKD
Kapitalizacja
198,43 mld
Śr. wol.
30,42 mln
Wolumen
55,18 mln
Wskaźnik C/Z
34,48
Najwyższa z 52 tyg.
58,00 HKD
Minimum z 52 tyg.
28,48 HKD
Zysk na akcję
1,40 HKD
Akcje w obiegu
1,23 mld
Liczba pracowników
15 tys.
Wiadomości
Ze źródeł internetowych i od partnerskich agencji informacyjnych
ad-hoc-news.de
·
2 godziny temu
WuXi Biologics stock last traded at EUR 5.42 on October 16, 2026 with a P/ E of 34.45
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
WuXi Biologics (Cayman) Inc – informacje
PrezesZhisheng Chen
Pracownicy14,7 tys.
Data założenia2010
Siedziba główna-
Sektor-
Witrynawuxibiologics.com